David Todd Dollinger
Executive Director
pharmaceutical
PCCL,Polymer competence centre Leoben
Israel
Biography
P-Cure was founded to expand the availability of proton therapy to benefit more patients, and to enhance the benefits that proton therapy brings to treating and curing cancer.
Research Interest
Pharmaceutical science
